|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.77 USD | +2.17% |
|
-2.54% | -1.53% |
| Jun. 12 | Masimo Corporation Announces Executive Appointments | CI |
| Jun. 10 | Masimo Announces the Findings of A Randomized Clinical Trial Published in Jama Pediatrics | CI |
Summary: Masimo Corporation
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Highlights: Masimo Corporation
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses: Masimo Corporation
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 40.84 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.54 times its current sales, is high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings Chart: Masimo Corporation
Source: Surperformance
ESG chart: Masimo Corporation
Source: MSCI
| Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
|---|---|---|---|---|---|
| - | - | 8.64B | |||
| 9.91B | |||||
| - | 5.5B | ||||
| 5.27B | |||||
| - | 4.93B | ||||
| 4.23B | |||||
| Average | 6.41B | ||||
| Weighted average by Cap. |
Investor (Composite)
-
Trader (Composite)
ESG MSCI
BB
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
-
Net Margin
Financial Health (Composite)
-
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
-
Dividend Yield
-
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- MASI Stock
- Ratings Masimo Corporation
Select your edition
All financial news and data tailored to specific country editions
